Safety of Different Weight-Based Dosing Strategies of Intravenous Acyclovir in Obese Patients: A Retrospective Cohort Study
In obese patients, either AdjBW or IBW dosing of IV acyclovir appears to be safer than TBW. The IBW dosing had the lowest odds of AKI among the 3 dosing strategies.
Authors
- Mohamed Saad (ORCID: https://orcid.org/0000-0002-2221-4216)
- Safeya Habib (ORCID: https://orcid.org/0000-0002-2586-9074)
- Islam Mohamed Salem (ORCID: https://orcid.org/0009-0005-1721-1706)
- Ahmed Mohammed Alhomosy (ORCID: https://orcid.org/0009-0009-8196-1412)
- Ola Mohamad Hishari
Institutions
- Hamad Medical Corporation (QA)
- Qatar University (QA)
Publication Details
- Journal
- Annals of Pharmacotherapy
- Published
- 2025-02-16
- DOI
- https://doi.org/10.1177/10600280251318017
- Citations
- 3
- Primary Topic
- Acute Kidney Injury Research
- Type
- article
- Field-Weighted Citation Impact
- 4.29